Analysts consider Ebos’ result a solid one

Analysts consider Ebos’ result a solid one
Jarden analysts have upgraded their rating for Ebos. (Image: Getty)
Ella Somers
Analysts feel upbeat but cautious about the future after healthcare wholesaler Ebos posted a better-than-expected full-year result on Wednesday.Jarden analysts Adrian Allbon and Nick Yeo upgraded their rating from underweight to neutral for the company.“Underlying cashflows were stronger than expected, with a beat on final dividend and lower net debt versus our expectations,” they wrote.Jarden's other highlights for the company included the LifeHealthcare acquisition performing “in line” with management expectations...

More Markets

Biden's big news, IT outage drags ASX to 11-day low
Markets ASX MARKET WRAP

Biden's big news, IT outage drags ASX to 11-day low

The ASX200 dropped 0.5% as US President Joe Biden stood down from his re-election bid.

AAP 8:00am
The change of heart behind Arvida’s US private equity buyout
Property

The change of heart behind Arvida’s US private equity buyout

The company’s share price rose 55% after the announcement.

NZ dollar at 11-week low on pending rate cuts, Biden's exit
Economy

NZ dollar at 11-week low on pending rate cuts, Biden's exit

The kiwi was trading below 60 US cents late Monday in Wellington. 

NZ sharemarket down 0.1% amid takeovers
Markets Market close

NZ sharemarket down 0.1% amid takeovers

The S&P/NZX 50 Index closed at 12,309.91, down 15.7 points or 0.13%.

Graham Skellern 22 Jul 2024